ZEALLogistics Solution Provider
Zealand Pharma A/S — Cash Flow Statement
₹59.50
+0.00%
Zealand Pharma A/S Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | 2.56 Cr | -18.68 Cr | 6.78 Cr | -5.65 Cr |
| Repayment Of Debt | -7.52 Cr | — | — | — |
| Issuance Of Capital Stock | 36.46 Cr | 0.00 | 0.00 | 0.00 |
| Capital Expenditure | -20.85 Cr | -9.64 Cr | -0.04 Cr | -0.49 Cr |
| End Cash Position | 5.08 Cr | 1.61 Cr | 5.08 Cr | 2.65 Cr |
| Beginning Cash Position | 1.61 Cr | 5.08 Cr | 2.65 Cr | 8.80 Cr |
| Changes In Cash | 3.46 Cr | -3.47 Cr | 2.43 Cr | -6.15 Cr |
| Financing Cash Flow | 22.88 Cr | 14.29 Cr | 0.14 Cr | -1.11 Cr |
| Interest Paid Cff | -1.68 Cr | -0.94 Cr | -0.08 Cr | -0.22 Cr |
| Cash Dividends Paid | -1.33 Cr | — | — | -0.02 Cr |
| Net Common Stock Issuance | 36.46 Cr | 0.00 | 0.00 | 0.00 |
| Common Stock Issuance | 36.46 Cr | 0.00 | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | -7.52 Cr | 15.40 Cr | 0.23 Cr | -0.87 Cr |
| Net Long Term Debt Issuance | -7.52 Cr | 15.40 Cr | 0.23 Cr | -0.87 Cr |
| Long Term Debt Payments | -7.52 Cr | — | — | — |
| Investing Cash Flow | -42.82 Cr | -8.74 Cr | -4.54 Cr | 0.12 Cr |
| Interest Received Cfi | 1.93 Cr | 0.25 Cr | 67000.00 | 0.26 Cr |
| Net Investment Purchase And Sale | -23.90 Cr | 0.66 Cr | -4.50 Cr | 0.35 Cr |
| Net PPE Purchase And Sale | -20.85 Cr | -9.64 Cr | -0.04 Cr | -0.49 Cr |
| Purchase Of PPE | -20.85 Cr | -9.64 Cr | -0.04 Cr | -0.49 Cr |
| Operating Cash Flow | 23.41 Cr | -9.03 Cr | 6.83 Cr | -5.16 Cr |
| Taxes Refund Paid | -4.16 Cr | -2.37 Cr | -2.24 Cr | -0.67 Cr |
| Change In Working Capital | 8.83 Cr | -22.02 Cr | -0.31 Cr | -8.95 Cr |
| Change In Other Current Liabilities | 5.23 Cr | 3.03 Cr | -0.36 Cr | 0.06 Cr |
| Change In Other Current Assets | -3.12 Cr | -13.27 Cr | -0.08 Cr | -0.12 Cr |
| Change In Payable | 12.29 Cr | -1.91 Cr | 5.52 Cr | -4.59 Cr |
| Change In Receivables | -5.66 Cr | -9.90 Cr | -5.42 Cr | -4.36 Cr |
| Other Non Cash Items | -0.43 Cr | 0.55 Cr | -0.10 Cr | -0.07 Cr |
| Depreciation And Amortization | 3.13 Cr | 0.91 Cr | 0.25 Cr | 0.18 Cr |
| Depreciation | 3.13 Cr | 0.91 Cr | 0.25 Cr | 0.17 Cr |
| Net Foreign Currency Exchange Gain Loss | 0.26 Cr | 0.66 Cr | 0.29 Cr | 0.37 Cr |
| Net Income From Continuing Operations | 15.77 Cr | 13.23 Cr | 7.12 Cr | 2.29 Cr |
| Issuance Of Debt | — | 15.40 Cr | — | — |
| Other Cash Adjustment Outside Changein Cash | — | -1000.00 | — | — |
| Long Term Debt Issuance | — | 15.40 Cr | — | — |
| Net Business Purchase And Sale | — | — | 0.00 | 0.00 |
| Purchase Of Business | — | — | 0.00 | 0.00 |
| Change In Inventory | — | — | 0.00 | 0.00 |
| Amortization Cash Flow | — | — | 35000.00 | 95000.00 |
| Gain Loss On Sale Of PPE | — | — | 0.00 | -0.08 Cr |
| Net Other Investing Changes | — | — | — | -1000.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Zealand Pharma A/S
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.